About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Solara Active Pharma Sciences Ltd.
Change Company
BSE Code
541540
ISIN Demat
INE624Z01016
Book Value
261.71
NSE Code
SOLARA
Dividend Yield %
0.00
Market Cap
28507.04
P/E
776.76
EPS
0.76
Face Value
10
1 Week
1 Month
3 Months
6 Months
1 Year
04-Dec-2025
Clarification On Volume Movement
19-Nov-2025
USFDA completes inspection at Solara Active Pharm...
19-Nov-2025
Solara Active Pharma Sciences informs about pres...
26-Sep-2025
Clarification sought from Solara Active Pharma S...
16-Aug-2025
Solara Active Pharma Sciences informs about recei...
25-Jul-2025
Solara Active Pharma Sciences informs about pres...
10-May-2025
USFDA concludes inspection at Solara’s Ambernath ...
07-May-2025
Solara Active Pharma Sciences submits board meeti...
06-May-2025
Solara Active Pharma informs about outcome of boa...
05-May-2025
Solara Active Pharma Sciences informs about shift...
30-Apr-2025
Solara Active Pharma Sciences incorporates wholly...
17-Apr-2025
Solara Active Pharma Sciences informs about cert...
07-Feb-2025
Solara Active Pharma Sciences informs about propo...
31-Jan-2025
Solara Active Pharma Sciences informs about earni...
29-Jan-2025
Solara Active Pharma Sciences informs about integ...
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.